Editorial
Published on 19 May 2023
Editorial: Pathogenesis of diabetic foot ulcers
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1218201
- 3,964 views
- 5 citations
Type at least 3 characters
1,462 articles
Clinical Trial
Published on 17 May 2023
A randomized, double-blind pilot study of analgesic and anti-inflammatory effects of naproxen sodium and acetaminophen following dental implant placement surgery
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1199580
- 4,337 views
- 2 citations
Original Research
Published on 15 May 2023
TRAF-STOP alleviates osteoclastogenesis in periodontitis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1119847
- 3,836 views
- 2 citations
Original Research
Published on 12 May 2023
PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1124633
- 3,145 views
- 2 citations
Correction
Published on 12 May 2023
Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1199951
- 2,407 views
- 4 citations
Original Research
Published on 11 May 2023
RNA-sequencing approach for exploring the protective mechanisms of dexmedetomidine on pancreatic injury in severe acute pancreatitis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1189486
- 3,402 views
- 1 citation
Original Research
Published on 10 May 2023
Dietary administration of the glycolytic inhibitor 2-deoxy-D-glucose reduces endotoxemia-induced inflammation and oxidative stress: Implications in PAMP-associated acute and chronic pathology
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.940129
- 3,934 views
- 6 citations
Original Research
Published on 09 May 2023
Modulation of gut microbiota alleviates cerebral ischemia/reperfusion injury in rats by inhibiting M1 polarization of microglia
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1123387
- 3,565 views
- 12 citations
Brief Research Report
Published on 09 May 2023
Potential impact of mepolizumab in stepping down anti-osteporotic treatment in corticosteroid-dependent asthma
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1183156
- 2,060 views
- 3 citations
Correction
Published on 09 May 2023
Corrigendum: Clostridium butyricum protects against pancreatic and intestinal injury after severe acute pancreatitis via downregulation of MMP9
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1197442
- 1,284 views
Correction
Published on 09 May 2023
Corrigendum: Cell volume restriction by mercury chloride reduces M1-like inflammatory response of bone marrow-derived macrophages
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1210999
- 1,236 views
Review
Published on 09 May 2023
Phytochemicals in the treatment of inflammation-associated diseases: the journey from preclinical trials to clinical practice
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1177050
- 14,404 views
- 53 citations
Brief Research Report
Published on 09 May 2023
Continuous IV infusion of anakinra
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1162742
- 6,821 views
- 6 citations
Mini Review
Published on 04 May 2023
One stone two birds: anti-inflammatory bronchodilators as a potential pharmacological strategy for COVID-19
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1185076
- 10,056 views
- 6 citations
Review
Published on 04 May 2023
Efficacy and safety of abrocitinib for moderate-to-severe atopic dermatitis in adolescents and adults: Meta-analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1154949
- 5,799 views
- 5 citations
Review
Published on 02 May 2023
Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1045997
- 4,683 views
- 7 citations